Conformis, Inc. – NASDAQ:CFMS

Financial Health
0
1
2
3
4
5
6
7
8
9

Conformis stock price monthly change

+0.89%
month

Conformis stock price quarterly change

+107.34%
quarter

Conformis stock price yearly change

+769.23%
year

Conformis key metrics

Market Cap
17.88M
Enterprise value
N/A
P/E
-0.25
EV/Sales
-0.13
EV/EBITDA
0.18
Price/Sales
0.20
Price/Book
0.23
PEG ratio
N/A
EPS
-5.71
Revenue
57.06M
EBITDA
-38.61M
Income
-41.5M
Revenue Q/Q
-14.85%
Revenue Y/Y
-5.71%
Profit margin
-81.34%
Oper. margin
-74.58%
Gross margin
37.41%
EBIT margin
-74.58%
EBITDA margin
-67.67%
Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

Conformis stock price history

Conformis stock forecast

Conformis financial statements

Conformis, Inc. (NASDAQ:CFMS): Profit margin
Sep 2022 13.78M -15.20M -110.29%
Dec 2022 17.42M -3.71M -21.33%
Mar 2023 12.83M -9.57M -74.56%
Jun 2023 13.02M -13.01M -99.91%
Conformis, Inc. (NASDAQ:CFMS): Debt to assets
Sep 2022 104593000 43.42M 41.52%
Dec 2022 94048000 39.86M 42.39%
Mar 2023 81923000 37.29M 45.53%
Jun 2023 67781000 35.75M 52.75%
Conformis, Inc. (NASDAQ:CFMS): Cash Flow
Sep 2022 -12.03M -607K 0
Dec 2022 -11.35M -321K 0
Mar 2023 -9.84M -907K 0
Jun 2023 -11.29M -308K 0

Conformis alternative data

Conformis, Inc. (NASDAQ:CFMS): Employee count
Aug 2023 295
Sep 2023 295
Oct 2023 295
Nov 2023 295
Dec 2023 295
Jan 2024 295
Feb 2024 295
Mar 2024 295
Apr 2024 295
May 2024 295
Jun 2024 295
Jul 2024 295

Conformis other data

20.35% -13.31%
of CFMS is owned by hedge funds
1.46M -970.57K
shares is hold by hedge funds

Conformis, Inc. (NASDAQ:CFMS): Insider trades (number of shares)
Period Buy Sel
Jul 2021 0 3749
Aug 2021 0 12493
Nov 2021 0 89953
Jan 2022 0 25249
Feb 2022 0 11537
May 2022 0 22396
Transaction Date Insider Security Shares Price per share Total value Source
Sale
AUGUSTI MARK A director, officer.. Common Stock 22,396 $0.46 $10,280
Sale
HOWE ROBERT S officer: CFO & TREASURER
Common Stock 11,537 $0.65 $7,511
Sale
AUGUSTI MARK A director, officer.. Common Stock 25,249 $0.75 $18,811
Sale
AUGUSTI MARK A director, officer.. Common Stock 40,000 $1.2 $48,000
Sale
AUGUSTI MARK A director, officer.. Common Stock 49,953 $1.2 $59,944
Sale
AUGUSTI MARK A director, officer.. Common Stock 5,000 $1.4 $7,000
Sale
AUGUSTI MARK A director, officer.. Common Stock 7,493 $1.42 $10,640
Sale
ALLDREDGE J BRENT officer: CLO & SE.. Common Stock 3,749 $1.47 $5,511
Sale
AUGUSTI MARK A director, officer.. Common Stock 4,781 $0.81 $3,873
Sale
AUGUSTI MARK A director, officer.. Common Stock 7,311 $0.8 $5,812
Patent
Application
Filling date: 2 Nov 2021 Issue date: 1 Sep 2022
Application
Filling date: 7 Dec 2021 Issue date: 24 Mar 2022
Application
Filling date: 22 Jun 2020 Issue date: 24 Mar 2022
Application
Filling date: 18 Oct 2021 Issue date: 17 Feb 2022
Grant
Filling date: 18 Mar 2020 Issue date: 25 Jan 2022
Application
Filling date: 2 Aug 2021 Issue date: 25 Nov 2021
Grant
Filling date: 14 Sep 2018 Issue date: 19 Oct 2021
Application
Filling date: 5 Apr 2021 Issue date: 22 Jul 2021
Application
Filling date: 3 Mar 2021 Issue date: 24 Jun 2021
Application
Filling date: 29 Dec 2020 Issue date: 13 May 2021
Tuesday, 16 January 2024
businesswire.com
Tuesday, 5 September 2023
globenewswire.com
Monday, 21 August 2023
globenewswire.com
Wednesday, 2 August 2023
zacks.com
globenewswire.com
Saturday, 24 June 2023
businesswire.com
Friday, 23 June 2023
prnewswire.com
businesswire.com
Market Watch
Monday, 8 May 2023
Zacks Investment Research
Seeking Alpha
Thursday, 13 April 2023
GlobeNewsWire
Monday, 6 March 2023
Zacks Investment Research
Wednesday, 1 March 2023
Seeking Alpha
Tuesday, 21 February 2023
GlobeNewsWire
Monday, 23 January 2023
GlobeNewsWire
Wednesday, 2 November 2022
Seeking Alpha
Zacks Investment Research
Wednesday, 5 October 2022
GlobeNewsWire
Monday, 29 August 2022
GlobeNewsWire
Tuesday, 9 August 2022
Seeking Alpha
Monday, 8 August 2022
Zacks Investment Research
Tuesday, 5 July 2022
GlobeNewsWire
Tuesday, 10 May 2022
GlobeNewsWire
Wednesday, 4 May 2022
Seeking Alpha
Zacks Investment Research
Monday, 11 April 2022
GlobeNewsWire
Thursday, 3 March 2022
Benzinga
Wednesday, 2 March 2022
Seeking Alpha
Friday, 18 February 2022
GlobeNewsWire
  • When is Conformis's next earnings date?

    Unfortunately, Conformis's (CFMS) next earnings date is currently unknown.

  • Does Conformis pay dividends?

    No, Conformis does not pay dividends.

  • How much money does Conformis make?

    Conformis has a market capitalization of 17.88M and it's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 37.86% to 62.05M US dollars.

  • What is Conformis's stock symbol?

    Conformis, Inc. is traded on the NASDAQ under the ticker symbol "CFMS".

  • What is Conformis's primary industry?

    Company operates in the Healthcare sector and Medical - Devices industry.

  • How do i buy shares of Conformis?

    Shares of Conformis can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • Who are Conformis's key executives?

    Conformis's management team includes the following people:

    • Mr. Mark A. Augusti Chief Executive Officer, Pres & Director(age: 59, pay: $989,400)
    • Mr. Robert S Howe Chief Financial Officer & Treasurer(age: 55, pay: $552,290)
    • Mr. J. Brent Alldredge J.D. Chief Legal Officer & Corporation Sec.(age: 50, pay: $470,500)
  • How many employees does Conformis have?

    As Jul 2024, Conformis employs 295 workers.

  • When Conformis went public?

    Conformis, Inc. is publicly traded company for more then 10 years since IPO on 1 Jul 2015.

  • What is Conformis's official website?

    The official website for Conformis is conformis.com.

  • Where are Conformis's headquarters?

    Conformis is headquartered at 600 Technology Park Drive, Billerica, MA.

  • How can i contact Conformis?

    Conformis's mailing address is 600 Technology Park Drive, Billerica, MA and company can be reached via phone at +7 813459001.

Conformis company profile:

Conformis, Inc.

conformis.com
Exchange:

NASDAQ

Full time employees:

295

Industry:

Medical - Devices

Sector:

Healthcare

Conformis, Inc., a medical technology company, develops, manufactures, and sells patient-specific products and instrumentation. The company offers personalized knee replacement products, including iUni, iDuo, a custom-made partial knee replacement option for either unicompartmental or bicompartmental osteoarthritis of the knee; iTotal CR, a cruciate retaining total knee replacement product; iTotal PS, a posterior stabilized knee replacement product, as well as provides iTotal Identity and Identity Imprint knee replacement products. It also provides Conformis Hip System and Cordera hip replacement, which are hip replacement products; and iJigs, a personalized single-use patient-specific instrumentation. The company markets and sells its products to orthopedic surgeons, hospitals, and other medical facilities through sales force, independent sales representatives, and distributors in the United States, Germany, the United Kingdom, Austria, Ireland, Switzerland, Spain, Portugal, the Netherlands, Belgium, the Dutch Antilles, Suriname, Australia, the United Arab Emirates, the Sultanate of Oman, Italy, Poland, and other markets. Conformis, Inc. was incorporated in 2004 and is headquartered in Billerica, Massachusetts.

600 Technology Park Drive
Billerica, MA 01821

CIK: 0001305773
ISIN: US20717E1010
CUSIP: 20717E101